tiprankstipranks
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market
KPRX
Kiora Pharmaceuticals
RESEARCH TOOLSreports
Want to see KPRX full AI Analyst Report?

Kiora Pharmaceuticals (KPRX) Income Statement

483 Followers

Kiora Pharmaceuticals Income Statement

Last quarter (Q1 2026), Kiora Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Kiora Pharmaceuticals's net income was $-2.42M. See Kiora Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 16.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -24.80K$ 16.00M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.43M$ 11.49M$ 12.59M$ 12.31M$ 14.24M
Depreciation and Amortization
$ 24.80K$ 19.20K$ 51.80K$ 41.61K$ 45.30K
EBITDA
$ -9.43M$ 5.70M$ -12.36M$ -13.65M$ -13.91M
Operating Income
$ -9.46M$ 4.51M$ -12.59M$ -12.31M$ -14.24M
Other Income/Expenses
$ -2.66M$ 1.15M$ 163.32K$ -1.39M$ 272.48K
Pretax Income
$ -12.12M$ 5.66M$ -12.42M$ -13.70M$ -13.96M
Net Income
$ -10.84M$ 3.59M$ -12.51M$ -13.58M$ -13.77M
Per Share Metrics
Basic EPS
$ -2.60$ 0.93$ -24.25$ -18.55$ -68.00
Diluted EPS
$ -2.64$ 0.87$ -24.25$ -18.55$ -68.00
Weighted Average Shares Outstanding
 4.17M 3.87M 538.01K 732.30K 241.10K
Weighted Average Shares Outstanding (Diluted)
 4.10M 4.13M 538.01K 732.30K 241.10K
Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History